Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia

This study has been completed.
Sponsor:
Information provided by:
Veloxis Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00504829
First received: July 18, 2007
Last updated: April 11, 2008
Last verified: April 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2008
  Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)
No publications provided by Veloxis Pharmaceuticals

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):